Effective April 23, 2026, the FDA removed twelve peptides from its Category 2 restricted compounding list after the original nominations were withdrawn, which eases the restriction on compounding them
Elevated IGF-1 promotes fibroblast proliferation, collagen synthesis, and inhibits matrix metalloproteinase activity
The accumulation of glucose and its metabolites in cells, for example in diabetes patients, enables this monosaccharide to interact with amino acid residues, which leads to the production of AGEs (168)
Ketogenic diet in epileptic children: impact on lipoproteins and oxidative stress
Increased levels of oxidative stress markers may suggest ongoing tissue damage and inflammation, assisting in determining the timing and intensity of antioxidant therapy as part of metabolic interventions (139)